V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10003055 | 10001967 | 1.76 | null | null | 2014-09-24 | 2014-09-26 | Hydroxycarbamide | N | N | 10459381 | HYDROXYCARBAMIDE |
| 10003056 | 10001968 | 1.67 | 50.8 | Palliative (P) | 2018-02-28 | 2018-03-08 | Cisplatin + Pemetrexed | N | null | 10459385 | CISPLATIN + PEMETREXED |
| 10003057 | 10001969 | 1.65 | 62.6 | Palliative (P) | 2016-11-14 | 2016-11-20 | PEMBROLIZUMAB | N | N | 10459388 | PEMBROLIZUMAB |
| 10003058 | 10001969 | 1.6 | 73.4 | Palliative (P) | 2016-09-04 | 2016-09-16 | Cisplatin + Pemetrexed | 2 | N | 10459388 | CISPLATIN + PEMETREXED |
| 10003059 | 10001970 | 1.58 | 92 | Palliative (P) | 2016-07-26 | 2016-08-23 | Gemcitabine weekly | N | N | 10459469 | GEMCITABINE |
| 10003060 | 10001971 | null | 66.6 | Disease modification (D) | 2014-12-28 | 2014-12-29 | Hydroxycarbamide | Y | N | 10459475 | HYDROXYCARBAMIDE |
| 10003061 | 10001972 | 1.75 | 56.6 | Palliative (P) | 2015-06-20 | 2015-06-20 | Trial Unspecified | null | N | 10459586 | TRIAL |
| 10003062 | 10001972 | 0 | 58 | Neo-adjuvant (N) | 2017-03-13 | 2017-03-22 | EOX | N | N | 10459586 | EOX |
| 10003063 | 10001973 | 1.73 | 0 | Curative (C) | 2018-02-28 | 2018-03-05 | R GCVP | 02 | N | 10459751 | CVP R |
| 10003064 | 10001974 | 1.82 | 74 | Disease modification (D) | null | 2018-05-19 | Hydroxycarbamide | N | N | 10459819 | HYDROXYCARBAMIDE |
| 10003065 | 10001974 | 1.62 | null | Palliative (P) | 2015-09-08 | 2015-09-09 | Cisplatin + Pemetrexed | 02 | N | 10459819 | CISPLATIN + PEMETREXED |
| 10003066 | 10001975 | null | 54.7 | Palliative (P) | 2017-11-26 | 2017-12-01 | Trial Unspecified | 1 | N | 10459904 | TRIAL |
| 10003067 | 10001976 | 0 | 90 | Adjuvant (A) | 2019-07-16 | 2019-07-21 | Gemcitabine 1000mg/m2 D1 8 15 | 2 | N | 10459979 | GEMCITABINE |
| 10003068 | 10001977 | 1.8 | 74 | Disease modification (D) | 2015-08-01 | 2015-08-01 | Hydroxycarbamide | N | N | 10460033 | HYDROXYCARBAMIDE |
| 10003069 | 10001978 | 1.73 | null | Disease modification (D) | 2013-12-04 | 2013-12-04 | PEMBROLIZUMAB | N | N | 10460051 | PEMBROLIZUMAB |
| 10003070 | 10001979 | 1.63 | 69.9 | Not known (9) | 2014-02-16 | 2014-03-02 | EOX | N | N | 10460074 | EOX |
| 10003071 | 10001980 | 1.63 | 77 | Curative (C) | 2016-09-26 | 2016-09-26 | Trial Unspecified | 01 | N | 10460077 | TRIAL |
| 10003072 | 10001981 | null | 65.4 | Palliative (P) | 2015-10-01 | 2015-10-15 | PEMBROLIZUMAB | N | N | 10460084 | PEMBROLIZUMAB |
| 10003073 | 10006344 | 1.77 | 0 | Disease modification (D) | 2016-03-05 | 2016-03-06 | Hydroxycarbamide | 2 | N | 10460096 | HYDROXYCARBAMIDE |
| 10003074 | 10006344 | null | 84.4 | Palliative (P) | 2017-06-26 | 2017-07-06 | Cisplatin + Pemetrexed | 02 | Y | 10460096 | CISPLATIN + PEMETREXED |
| 10003075 | 10001982 | 1.66 | 59 | Palliative (P) | 2015-05-23 | 2015-05-23 | Rituximab (Maintenance) | N | null | 10460100 | RITUXIMAB |
| 10003076 | 10001982 | 1.73 | 69 | Adjuvant (A) | 2019-01-05 | 2019-01-15 | Cisplatin + Vinorelbine (IV) | 2 | N | 10460100 | CISPLATIN + VINORELBINE |
| 10003077 | 10001982 | 1.65 | 0 | Disease modification (D) | 2017-07-14 | 2017-07-19 | R GCVP | N | N | 10460100 | CVP R |
| 10003078 | 10001982 | 1.68 | 93.3 | Palliative (P) | 2016-01-25 | 2016-02-18 | Cisplatin + Pemetrexed | N | N | 10460100 | CISPLATIN + PEMETREXED |
| 10003079 | 10001983 | 1.7 | null | Neo-adjuvant (N) | 2016-09-06 | 2016-11-06 | ECX | 02 | N | 10460199 | ECX |
| 10003080 | 10001984 | 1.64 | 70 | Adjuvant (A) | 2015-08-15 | 2015-09-05 | Carboplatin + Vinorelbine Oral | N | N | 10460203 | CARBOPLATIN + VINORELBINE |
| 10003081 | 10001985 | 1.65 | null | Adjuvant (A) | 2017-12-16 | 2017-12-31 | Cisplatin + Vinorelbine (IV) | N | N | 10460257 | CISPLATIN + VINORELBINE |
| 10003082 | 10001985 | 1.7 | 86.6 | Palliative (P) | 2014-07-01 | 2014-07-12 | GEMCITABINE | 02 | N | 10460257 | GEMCITABINE |
| 10003083 | 10008050 | 1.8 | 0 | Palliative (P) | 2018-07-25 | 2018-08-05 | Rituximab | N | N | 10460307 | RITUXIMAB |
| 10003084 | 10001986 | 1.61 | null | Palliative (P) | 2018-07-21 | 2018-08-08 | Cisplatin + Pemetrexed | 02 | N | 10460324 | CISPLATIN + PEMETREXED |
| 10003085 | 10001987 | 1.8 | 60.95 | Palliative (P) | 2017-05-12 | 2017-05-21 | ECX | N | N | 10460331 | ECX |
| 10003086 | 10006347 | 1.71 | 61.4 | Disease modification (D) | 2016-01-29 | 2016-02-14 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 10460380 | RITUXIMAB |
| 10003087 | 10001988 | 1.69 | 69.3 | Adjuvant (A) | 2016-08-03 | 2016-08-10 | CISPLATIN + VINORELBINE | N | Y | 10460413 | CISPLATIN + VINORELBINE |
| 10003088 | 10001988 | 0 | 69.2 | Disease modification (D) | 2017-09-02 | 2017-09-02 | Hydroxycarbamide | N | null | 10460413 | HYDROXYCARBAMIDE |
| 10003089 | 10001989 | 1.87 | 80.9 | Palliative (P) | 2017-10-08 | 2017-10-19 | Trial Unspecified | Y | N | 10460506 | TRIAL |
| 10003090 | 10006349 | 1.7 | 92.6 | Palliative (P) | 2017-11-22 | 2017-11-29 | Cisplatin + Pemetrexed | 02 | N | 10460509 | CISPLATIN + PEMETREXED |
| 10003091 | 10006349 | null | 45 | Curative (C) | 2016-08-13 | 2016-08-15 | CVP R | 02 | N | 10460509 | CVP R |
| 10003092 | 10001990 | 1.52 | 66.1 | Neo-adjuvant (N) | 2018-10-20 | 2018-11-02 | ECX | N | N | 10460567 | ECX |
| 10003093 | 10001990 | 1.8 | 83.8 | Adjuvant (A) | null | 2017-12-17 | CISPLATIN + VINORELBINE | N | N | 10460567 | CISPLATIN + VINORELBINE |
| 10003094 | 10001990 | 0 | 84.5 | Palliative (P) | 2017-12-01 | 2017-12-08 | ECX | N | N | 10460567 | ECX |
| 10003095 | 10001990 | 1.8 | 57.6 | Palliative (P) | 2017-09-19 | 2017-09-25 | Cisplatin + Pemetrexed | N | null | 10460567 | CISPLATIN + PEMETREXED |
| 10003096 | 10001990 | 1.77 | 130 | Palliative (P) | 2018-09-01 | 2018-09-04 | Enzalutamide | 02 | N | 10460567 | ENZALUTAMIDE |
| 10003097 | 10001990 | 1.63 | 64.8 | Palliative (P) | 2016-08-24 | 2016-09-28 | Cisplatin + Pemetrexed | 2 | N | 10460567 | CISPLATIN + PEMETREXED |
| 10003098 | 10001991 | null | 78 | Curative (C) | 2017-07-10 | 2017-07-15 | R GCVP | 02 | N | 10460776 | CVP R |
| 10003099 | 10001992 | 1.75 | 76.4 | Palliative (P) | 2016-08-04 | 2016-08-04 | PEMBROLIZUMAB | N | N | 10460803 | PEMBROLIZUMAB |
| 10003100 | 10006351 | 1.63 | 88.3 | Palliative (P) | 2016-12-18 | 2017-01-04 | Enzalutamide | 2 | N | 10460823 | ENZALUTAMIDE |
| 10003101 | 10006351 | null | 55.6 | Palliative (P) | 2018-10-17 | 2018-10-17 | EOX | N | N | 10460823 | EOX |
| 10003102 | 10006351 | 0 | 87.6 | Palliative (P) | 2014-07-14 | 2014-07-21 | ECX | 2 | N | 10460823 | ECX |
| 10003103 | 10006351 | 1.64 | 72.6 | Palliative (P) | 2017-01-18 | 2017-01-26 | PEMBROLIZUMAB | null | N | 10460823 | PEMBROLIZUMAB |
| 10003104 | 10001993 | 1.71 | 75.4 | Curative (C) | 2014-11-26 | 2014-11-27 | Carboplatin + Vinorelbine Oral | 02 | null | 10460943 | CARBOPLATIN + VINORELBINE |